InvestorsHub Logo

elvis-is-here

10/16/20 5:51 PM

#35341 RE: lazoom #35337

ENZC 95% HIV Success. 1/2 Trillion$ Spent on HIV/AIDS:
http://www.healthdata.org/news-release/first-long-term-study-finds-half-trillion-dollars-spent-hivaids

BioClonetics is in the final stage of development of a parent monoclonal antibody ("mAbs") (designated as Clone 3), which is non-toxic and has shown in initial in vitro testing to be effective against more than 95% of all strains and viral subtypes of HIV-1 against which it has been tested.

https://www.accesswire.com/610379/Enzolytics-Inc-Announces-Execution-of-Binding-Letter-of-Intent-for-Merger-with-BioClonetics-Immunotherapeutics-Inc

Letter of Intent Executed!!!!